Brownsville Moves to Level 2 On Threat Level Matrix

Translate to Spanish or other 102 languages!

Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. Image for illustration purposes
Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. Image for illustration purposes

Mega Doctor News

- Advertisement -

BROWNSVILLE, Texas – Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. During the past two weeks, virus transmission rates have increased, especially for unvaccinated individuals.

The number of positive COVID-19 cases has surpassed 1,000 cases, with two confirmed deaths this week. The public must stay vigilant and aware that this can take a toll on every member of the community, including the most vulnerable and healthcare staff. 

“We want to remind citizens that it is essential to continue to be vigilant and practice safe health practices. Please remember to wash your hands, use hand sanitizer, practice social distancing, and wear a mask,” said Dr. Rodriguez.

- Advertisement -

Currently, the vaccination rate for Cameron County is at 92.80% for individuals 65 years and older and 81.83% for people five years and older.  Getting the COVID-19 vaccine has been found to be the safest and most effective way to protect the immune system from COVID-19. Call the COVID-19 Hotline at 956-394-0012 or visit the Brownsville Cares website for more information regarding COVID-19 vaccines.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -